High-Containment Research Services for Infectious Disease Programs
SPECIALIZED EXPERTISE FOR COMPLEX PATHOGEN RESEARCH
Advancing research involving emerging and high-consequence pathogens requires more than laboratory space. It requires access to specialized containment infrastructure, experienced scientific teams, and the technical capabilities needed to support complex development programs. Microbiologics helps organizations overcome the challenges of working with high-containment pathogens through integrated capabilities that include viral stock production, pathogen characterization, assay development, inactivation methods, and custom research services, all supported by rigorous quality systems and biosafety practices.
The Challenges of High-Containment Pathogen Research
Research involving emerging and high-consequence pathogens presents unique scientific, operational, and biosafety challenges. Organizations developing vaccines, therapeutics, diagnostics, and public health solutions often require access to specialized containment laboratories, experienced scientific personnel, and well-characterized biological materials that demand significant investment and ongoing operational oversight.
Beyond containment infrastructure, research programs must balance biosafety requirements, material availability, study timelines, and data quality expectations. Accessing relevant pathogen strains, generating fit-for-purpose biological materials, validating inactivation approaches, and developing reliable testing methods can create significant operational complexity. For many organizations, maintaining these capabilities in-house is impractical, leading them to seek partners with the expertise, infrastructure, and technical resources needed to advance programs efficiently and responsibly.
Supporting Research Across High-Containment Pathogens
Microbiologics supports research involving a range of emerging and high-consequence pathogens that are important to vaccine development, therapeutic evaluation, diagnostic development, and public health preparedness. Explore several examples of the pathogen research programs supported by our high-containment capabilities.
Highly Pathogenic Avian Influenza (HPAI)
As concerns around pandemic preparedness and zoonotic disease transmission continue to grow, Highly Pathogenic Avian Influenza (HPAI) remains a key focus of global research efforts. Scientists and vaccine developers are actively evaluating emerging strains and their potential impact on animal and human health.
Researchers studying HPAI can leverage Microbiologics' high-containment capabilities for viral stock production, pathogen characterization, viral inactivation, assay development, and custom research services involving strains such as H5 and H7.
Highly Pathogenic Avian Influenza (HPAI)
Coronavirus (SARS-CoV-2 and SARS-CoV-1)
The emergence of SARS-CoV-2 renewed global interest in coronavirus biology and highlighted the importance of preparedness for future outbreaks. Ongoing research involving SARS-CoV-2, SARS-CoV-1, and related coronaviruses continues to advance the development of vaccines, therapeutics, diagnostics, and strategies for responding to emerging infectious disease threats.
Through integrated high-containment capabilities, Microbiologics helps researchers access the biological materials, testing services, and scientific expertise needed to support complex coronavirus research programs.
Coronavirus (SARS-CoV-2 and SARS-CoV-1)
Emerging and Vector-Borne Viral Pathogens
From Mpox and Vaccinia virus to West Nile virus (WNV), Chikungunya virus (CHIKV), Eastern Equine Encephalitis Virus (EEEV), and Western Equine Encephalitis Virus (WEEV), emerging viral pathogens continue to present evolving challenges for public health and infectious disease research. Understanding transmission, pathogenesis, immune responses, and opportunities for prevention remains critical to advancing countermeasures and preparedness efforts.
Microbiologics supports research involving a broad range of emerging and vector-borne viral pathogens through viral stock production, pathogen characterization, viral inactivation, assay development, and custom research services designed to help accelerate scientific discovery and development programs.
Emerging and Vector-Borne Viral Pathogens
Mycobacterium tuberculosis (Mtb)
Despite decades of research, tuberculosis remains one of the world's leading infectious disease threats and continues to drive efforts to improve diagnostics, therapeutics, and prevention strategies. The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains has further increased the need for innovative approaches to tuberculosis research and drug development.
Research involving Mycobacterium tuberculosis often focuses on antimicrobial susceptibility testing, drug discovery and development, diagnostic evaluation, pathogen characterization, and studies designed to better understand mechanisms of resistance and disease progression. These programs require specialized containment capabilities, experienced scientific personnel, and access to well-characterized bacterial strains.
Microbiologics supports tuberculosis research through integrated high-containment capabilities, including pathogen characterization, in vitro testing, assay development, antimicrobial susceptibility testing, and custom research services. Our scientific teams help customers generate reliable data and advance programs focused on addressing one of the world's most persistent infectious diseases.
Mycobacterium tuberculosis (Mtb)
Why Partner with Microbiologics for High-Containment Research?
Organizations working with high-containment pathogens need more than access to specialized laboratory space. They need a partner capable of delivering reliable materials, scientific expertise, and quality-driven support throughout the research and development process. Microbiologics combines high-containment infrastructure, virology expertise, and commercial-grade quality systems to help customers advance complex infectious disease programs from early research through clinical development.
Specialized Scientific Expertise
Our experienced virologists, microbiologists, and research teams understand the unique challenges associated with emerging and high-consequence pathogens. We work closely with customers to support study design, material selection, assay development, and data generation aligned with program objectives.
Commercial-Grade Quality Systems
Research programs depend on consistency, traceability, and reliable documentation. Microbiologics supports high-containment projects through established quality systems, well-characterized materials, and the documentation needed to support research, development, and regulatory activities.
Integrated Research Capabilities
From viral stock production and pathogen characterization to assay development, viral inactivation, and clinical support services, our integrated capabilities help streamline project execution and reduce the complexity of managing multiple vendors.
A Trusted Partner for Complex Programs
Building and maintaining specialized containment capabilities requires significant investment in infrastructure, expertise, operational oversight, and program governance. Microbiologics helps organizations navigate these complexities through integrated scientific support, coordinated program execution, and the resources needed to advance complex research initiatives while remaining focused on their core development objectives.
Integrated Capabilities for Infectious Disease Research
From pathogen characterization and viral stock production to vaccine testing and genomic analysis, Microbiologics provides specialized services that support every stage of infectious disease research and development. Explore our related capabilities to learn how we can help advance your program.
LET’S DISCUSS YOUR HIGH-CONTAINMENT RESEARCH.
Whether you're developing vaccines, therapeutics, diagnostics, or public health solutions, our team can help determine the right approach to support your high-containment research needs.